Share |
 Article not rated yet 

Childhood and Adolescence PrevInfad/PAPPS Group

Metabolic neonatal screening


Galbe Sánchez-Ventura Ja, Grupo PrevInfad/PAPPS Infancia y Adolescencia b

aPediatra. CS Torrero La Paz. Zaragoza. España.
bJosé María Mengual Gil (coord.).

Correspondence: J Galbe. Email:

Reference of this article.:

Galbe Sánchez-Ventura J, Grupo PrevInfad/PAPPS Infancia y Adolescencia . Cribado neonatal de metabolopatías. Rev Pediatr Aten Primaria. 2009;11:471-84.

Published in Internet: 30/09/2009


Since the end of the seventies, many countries started programs on metabolic neonatal screening focused on early detection and diagnosis of those metabolic congenital disorders which, detected in the first days of life, were subject of treatment. Therefore prognosis of some of these diseases has improved notably. Initially the programs included the screening of phenylketonuria and congenital hypothyroidism, being extended later to the detection to congenital suprarenal hyperplasia and pancreatic cystic fibrosis. Recently the introduction of tandem mass spectrometry has allowed the screening of many metabolic diseases; nevertheless many of them do not match the minimal criteria to be included in a public health screening program.

Keywords: Prevention. Neonatal screening. Congenital metabolic diseases.



This article has no comments yet.

ISSN 2174-4106  Publicación Open Acess, incluida en DOAJ, sin cargo por publicación.

Privacy Policy | Web map | Copyright 2021 Lúa Ediciones 3.0 | Contact